Bahamas vs Barbados: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bahamas
85.0%
in 2025
Barbados
85.0%
in 2025
Bahamas rank
94th
Barbados rank
94th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bahamas
- Barbados
How they compare
Bahamas currently reports 85.0% against 85.0% in Barbados, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Barbados ahead.
Bahamas ranks 94th and Barbados ranks 94th of 192 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | Barbados | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 37.5% | 36.0% | Barbados |
| 2010s | 69.3% | 88.4% | 19.1% | Barbados |
| 2020s | 83.0% | 85.5% | 2.5% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bahamas or Barbados?
- Bahamas, at 85.0% against 85.0% in Barbados as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bahamas and Barbados?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Barbados?
- 18 years are reported by both, from 2008 to 2025.
- How do Bahamas and Barbados rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bahamas ranks 94th and Barbados ranks 94th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.